Friday, July 20, 2018
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at page facebook
VWR and E&I Cooperative Services Sign Contract to Benefit E&I Members
(July 12, 2018)

RADNOR, Pa., July 12, 2018 /PRNewswire/ -- VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and leading global provider of product and service solutions to laboratory and production customers, has been awarded a five-year laboratory supplies and services contract by E&I Cooperative Services (E&I), effective July 1, 2018.


E&I is the only member-owned, non-profit purchasing cooperative solely focused on serving the needs of education. Providing over 120 competitively awarded contracts and dedicated member resources nationwide, E&I is a trusted advisor to the education community, leveraging the purchasing power of over 4,600 members to help higher education and K-12 institutions optimize supply-chain efficiencies, lower costs and reduce risks.

This new five-year contract, with a five-year extension option, was awarded to VWR by E&I after an extensive competitive request for proposal (RFP) process. The E&I RFP process is validated by the National Institute of Government Purchasing (NIGP) and meets the needs of EDGAR/Uniform Guidance. All proposals were scored against strict criteria such as breadth and depth of products and value-added solutions offered and additional discounts, incentives, and value for members.

"We are excited to continue our ongoing relationship with VWR," stated Tom Fitzgerald, Chief Executive Officer, E&I. "E&I is committed to ensuring our members utilize only best-in-class contracts, and the value brought by VWR directly reflects our core mission. We are proud to be able to offer this enhanced contract to our members nationwide."

"This new contract will support a diverse membership across K-12, higher education, and the healthcare industry," shared Jay Hexamer, Senior Vice President, Education & Medical Research and Healthcare, Americas Sales for VWR. "Through continued collaboration, we look forward to providing solutions that meet the evolving industry demands, ultimately, supporting the E&I members to set science in motion."

About VWR
Acquired by Avantor in 2017 as a wholly-owned subsidiary, VWR serves as a leading global provider of product and service solutions to laboratory and production customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. The combined company is a trusted end-to-end partner to customers and suppliers from discovery to delivery. With operations in more than 30 countries and a diverse portfolio that includes more than four million branded and manufactured products, we enable customer success through innovation, cGMP manufacturing and comprehensive service offerings. Collectively, we set science in motion to create a better world. For more information visit or

Media Contact:
Valerie Collado
VWR, part of Avantor
[email protected]


Cision View original content with multimedia:


Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Science,Medical,Science,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally -

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines